Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1983 Apr;42(2):138–141. doi: 10.1136/ard.42.2.138

Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.

C Rajapakse, R Thompson, D M Grennan, B M Winston, P Patel, P M Nuttall, J Murphy, J B Weiss
PMCID: PMC1001086  PMID: 6221703

Abstract

Bone metabolism in 21 patients with rheumatoid disease was investigated by measurement of the 24-hour whole body retention (WBR) of 99Tcm methylene diphosphonate (MDP) in parallel with clinical, radiological, and biochemical measurements (urinary excretion of hydroxyproline) of disease activity. Corticosteroid-treated patients of those with other forms of metabolic bone disease were excluded from the study. WBR was increased in the rheumatoid patients as compared with 21 age- and sex-matched controls (p less than 0.05), and there was a significant correlation in the rheumatoid group between WBR and urinary excretion of hydroxyproline (p less than 0.01) and between urinary excretion of hydroxyproline and an articular index (p less than 0.05) and global index (p less than 0.01) of disease activity. The increased WBR of the rheumatoid patients was not explicable by factors such as immobilisation, and the results are interpreted as reflecting an overall increase in bone metabolism which may occur in rheumatoid arthritis as part of the disease process.

Full text

PDF
138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Duncan H., Frost H. M., Villanueva A. R., Sigler J. W. The osteoporosis of rheumatoid arthritis. Arthritis Rheum. 1965 Oct;8(5):943–954. doi: 10.1002/art.1780080504. [DOI] [PubMed] [Google Scholar]
  2. Guillemart A., Besnard J. C., Le Pape A., Galy G., Fetissoff F. Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography. J Nucl Med. 1978 Aug;19(8):895–899. [PubMed] [Google Scholar]
  3. Kaye M., Silverton S., Rosenthall L. Technetium-99m-pyrophosphate: studies in vivo and in vitro. J Nucl Med. 1975 Jan;16(1):40–45. [PubMed] [Google Scholar]
  4. Kennedy A. C., Lindsay R., Buchanan W. W., Allam B. F. Bone-resorbing activity in the sera of patients with rheumatoid arthritis. Clin Sci Mol Med. 1976 Aug;51(2):205–207. doi: 10.1042/cs0510205. [DOI] [PubMed] [Google Scholar]
  5. Kennedy A. C., Smith D. A., Anton H. C., Buchanan W. W. Generalised and localised bone loss in patients with rheumatoid arthritis. Scand J Rheumatol. 1975;4(4):209–215. doi: 10.3109/03009747509165258. [DOI] [PubMed] [Google Scholar]
  6. Larsen A., Dale K., Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977 Jul;18(4):481–491. doi: 10.1177/028418517701800415. [DOI] [PubMed] [Google Scholar]
  7. Manicourt D., Orloff S., Rao V. H. Synovial fluid and serum hydroxyproline fractions in rheumatoid arthritis. Scand J Rheumatol. 1979;8(3):161–167. doi: 10.3109/03009747909114449. [DOI] [PubMed] [Google Scholar]
  8. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  9. Rohlin M., Nosslin B. Quantitative analysis of the distribution of 99mTc-labelled ethylene hydroxy diphosphonate in young rats. Eur J Nucl Med. 1977 Jun 30;2(2):113–115. doi: 10.1007/BF00253683. [DOI] [PubMed] [Google Scholar]
  10. Rosenspire K. C., Kennedy A. C., Steinbach J., Blau M., Green F. A. Investigation of the metabolic acitivity of bone in rheumatoid arthritis. J Rheumatol. 1980 Jul-Aug;7(4):469–473. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES